Nanobiotix SA - ADRNBTX
13F holders, Q1 2026 (March 31)15holders +1
2new positions
1sold out
$30.87avg. 13F price*
At the end of Q1 2026, 15 institutions reported holding Nanobiotix SA - ADR (NBTX) in their 13F filings, up 1 from Q4 2025. 2 opened new positions and 1 sold out. The largest holders were Johnson & Johnson ($173.6M), Morgan Stanley ($1.1M) and Optiver Holding B.V. ($417K).
- Company
- Nanobiotix SA - ADR
- CUSIP
- 63009J107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $62 |
| Exits | 1 | $390K |
All 13F filers, Q4 2025 → Q1 2026: 17,979 shares bought and 20,756 shares sold, net −2,777 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Johnson & Johnson | 26.61% | No change | 5,623,816 | $173.6M |
| Morgan Stanley | 0.00% | Add +58.2% | 36,274 | $1.1M |
| Optiver Holding B.V. | 0.02% | Reduce -16.8% | 13,501 | $417K |
| Marshall Wace, LLP | 0.00% | Reduce -2.8% | 9,239 | $285K |
| UBS Group AG | 0.00% | Add +263.2% | 5,557 | $172K |
| BNP Paribas Financial Markets | 0.00% | Reduce -1.1% | 3,559 | $110K |
| Rhumbline Advisers | 0.00% | Reduce -2.6% | 2,281 | $70K |
| Royal Bank of Canada | 0.00% | Reduce -30.5% | 1,825 | $56K |
| GAMMA Investing LLC | 0.00% | Add +261.6% | 828 | $26K |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 514 | $16K |
| Osaic Holdings, Inc. | 0.00% | No change | 500 | $15K |
| Wells Fargo & Company | 0.00% | No change | 200 | $6K |
| National Bank of Canada | 0.00% | No change | 13 | $394 |
| Citigroup Inc. | 0.00% | New | 1 | $31 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1 | $31 |
"% of holder's portfolio" is NBTX's weight in each manager's 13F, not the share of Nanobiotix SA - ADR the manager owns.